June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Comparison and Correlation of Schirmer’s Tests Results in Patients with Neuropathic Corneal Pain and Dry Eye Disease
Author Affiliations & Notes
  • Anya de Leeuw
    Tufts Medical Center, Boston, Massachusetts, United States
  • Brendan Kenyon
    Tufts University School of Medicine, Boston, Massachusetts, United States
  • Stephanie Cox
    Tufts Medical Center, Boston, Massachusetts, United States
  • Leyla Yavuz-Saricay
    Tufts Medical Center, Boston, Massachusetts, United States
  • Pedram Hamrah
    Tufts Medical Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Anya de Leeuw, None; Brendan Kenyon, None; Stephanie Cox, None; Leyla Yavuz-Saricay, None; Pedram Hamrah, Coopervision (F), Dompe (F), Novartis (F), Ocunova (F), Oysterpoint (F), Santen (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1279. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anya de Leeuw, Brendan Kenyon, Stephanie Cox, Leyla Yavuz-Saricay, Pedram Hamrah; Comparison and Correlation of Schirmer’s Tests Results in Patients with Neuropathic Corneal Pain and Dry Eye Disease. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1279.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neuropathic corneal pain NCP is commonly thought to present with discordant signs and symptoms with minimal to no ocular surface staining. However, the Schirmer’s test result in patients with NCP have previously not been compared to patient with conventional dry eye disease DED. Thus, the purpose of the current study was to compare Schirmer’s test results between patients with NCP as compared to DED.

Methods : This is a comparative, retrospective case-control study of age and sex matched NCP and DED patients, who were seen at the New England Eye Center between August 2018 and November 2020. NCP was diagnosed clinically and confirmed by in vivo confocal microscopy and the proparacaine challenge. Demographics, Schirmer’s test results with anesthesia, tear-break-up time TBUT, corneal staining CFS, ocular pain scores, ocular and systemic comorbidities were recorded. Patients were included in the DED group, based on the inclusion criteria of CFS staining≥4 and TBUT≤7.

Results : The mean age of patients with NCP was 45.7±4.9 with n=4 males and n=19 females, and 63.1±3.9 for the DED group with n=5 males, and n=14 females p=0.199 for age p=0.707 for gender. The mean Schirmer’s tests results for the NCP group were 9.8mm±1.8 and 7.1mm±1.1 for the DED group, respectively with a p value of p=0.450. This indicated no significant difference in Schirmer’s results between the DED and NCP patients, with both groups demonstrating decreased results compared to healthy subjects. There was no difference in Schirmer’s results in the NCP group regardless of breakdown into peripheral n=3 mean 8.67±5.78, mixed n=9 mean 12.33±2.73 and central n=3 mean 5.00±1.16 p=0.383. The mean TBUT for the DED group was 4.0sec±0.4 and 10.2sec±0.5 for the NCP group p= <.001. The mean CFS was 4.1±1.0 for DED, and 0.4±0.2 for the NCP group p=.011. DED patients reported a mean pain level of 1.9±0.7on VAS, while NCP patients reported VAS of 4.5±0.3 p=.002. DED patients reported a mean of 1.8±0.7 on OPAS questions 5-7 indicating pain over the previous 24hr period, while NCP patients reported 5.0±0.7 p=.001.

Conclusions : The results of this study shows that NCP patients may present with low values on Schirmer’s tests in the absence of clinical signs of DED. The data suggests that abnormal Schirmer’s test results may be due to nerve dysfunction and that abnormal Schirmer’s tests results should not be used to exclude NCP.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×